Developing medicines is a long intricate process that involves several players and stakeholders. It requires a huge number of financial resources coupled with infrastructure and skilled manpower. The entire agglomeration of these several players is interconnected and dependent on each other for financing every incremental step of innovation and development. This creates an interconnected ecosystem.…
admin
Digital technology has influenced our life greatly in this 21st century. This revolution began somewhere in the mid-20th century and as of today it has revolutionized various aspects of our life. It is therefore no surprise that the healthcare sector is one of the beneficiaries of this digital revolution. In the simplest terms, electronic tools,…
Digital technology can be accessed at fingertips and a boon for a researcher to stay in touch with the participants 24 x 7 using smart devices. The compatibility of the clinical trial digital technology with any of the smartphones makes implementation simple and user friendly. These features of digital clinical trials have caught the attention…
Digital technologies have significantly transformed the landscape of clinical trials, offering a range of tools to improve patient access, enrollment and engagement as well as on time data collection with reduced time lags and thus improving the overall trial management. Some of the key digital technologies commonly used in clinical trials include:
Electronic Data…
Pharmacogenomics has triggered research and development in this area of personalized patient care and has resulted in several key industry players investing in it to be a big player for tomorrow. The most important sectors that are influenced by pharmacogenomic studies are the pharmaceutical industry and the healthcare sector. The regulatory bodies are slowly trying…
Pharmacogenomics is a new branch of pharmaceutical research that has gained momentum. The influence of an individual's genetic makeup on response to medicines has a profound impact on multiple industries due to its potential to revolutionize personalized medicine.
We all are governed by the genes that we carry and the idea of the impact of…
Pharmacogenomics is a new area in the field of medicine. As the word suggests, it is the area that works as the link between the actions of the medicine based on genetic make-up of an individual. Thus, it is an extremely complex area that is still new and emerging. Pharmacogenomics therefore primarily focuses on how a…
Pharmacogenomics is the study of how a person's genetic composition influences the activity of medicines consumed. Thus, it entails investigating how an individual's genetic differences affect medication metabolism, the chance of encountering adverse drug reactions, and response to specific treatments. The goal of pharmacogenomics is to create more effective and safer drugs while also personalizing…
Australia remains one of the important markets of the continent with major contributions to the healthcare and pharmaceutical industry. As a part of major revamping of the pharmaceutical sector and to align with the western world, the regulations governing medications and medical devices underwent significant change under the government directive in October 2014. The regulatory…
Clinical trial success depends on the selection of a clinical trial site. A "right site" for clinical trials is defined as a location that possesses the necessary resources, including infrastructure, experienced personnel, and access to an appropriate patient population, allowing for the successful and ethical execution of clinical research studies. Selecting the right site for clinical…